home / stock / casi / casi news

CASI News and Press, CASI Pharmaceuticals Inc. From 04/21/19

Stock Information
Company Name: CASI Pharmaceuticals Inc.
Stock Symbol: CASI
Market: NASDAQ
Website: casipharmaceuticals.com
Menu
CASI CASI Quote CASI Short CASI News CASI Articles CASI Message Board
Get CASI Alerts

News, Short Squeeze, Breakout and More Instantly...
CASI - Week In Review: Chi-Med Plans $500 Million Hong Kong IPO

Deals and Financings Hutchison China MediTech (Chi-Med) [AIM:HCM] (HCM) filed to IPO on the Hong Kong Exchange, following listings in London and on NASDAQ, where it has a market capitalization of over $4 billion (see story ). In September 2018, Chi-Med was approved to launch fruquintinib in...
CASI - CASI Pharma in-licenses rights to TSK011010 from Black Belt Therapeutics; shares up 5% premarket

CASI Pharmaceuticals (NASDAQ: CASI ) has signed a license agreement for exclusive worldwide rights to investigational anti-CD38 monoclonal antibody (Mab) TSK011010 program from Black Belt Therapeutics Limited. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, St...

CASI - CASI Pharmaceuticals In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt Therapeutics

ROCKVILLE, Md. , April  17, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. pharmaceutical company with a platform to develop and accelerate the launch of innovative therapeutics and pharmaceutical products in China , the U.S., and throughout the world, ann...

CASI - CASI Pharmaceuticals Announces The Appointment Of Wei-Wu He, Ph.D., Executive Chairman, To The Role Of Chief Executive Officer

ROCKVILLE, Md. , April 2, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China , the U.S., and throughout the world, ...
CASI - CASI Pharmaceuticals misses by $0.02

CASI Pharmaceuticals (NASDAQ: CASI ): Q4 GAAP EPS of -$0.10 misses by $0.02. More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

CASI - CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2018 Financial Results And Business Results

ROCKVILLE, Md. , March 29, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China , U.S., and throughout the world, today repor...

CASI - Week In Review: Inventis Closes $70 Million Financing To Develop 30 Novel Therapeutics

Deals and Financings InventisBio of Shanghai closed a $70 million Series C financing co-led by Advantech Capital and CMBI, followed by Pudong Innotek (see story ). Founded in 2013, InventisBio focuses on discovering and developing novel therapeutics for cancer and metabolic diseases. The co...
CASI - CASI Pharmaceuticals Announces Exclusive Distribution Partner For Melphalan Hydrochloride For Injection (EVOMELA®) In China

ROCKVILLE, Md. , March 13, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China , U.S., and throughout the world,&#x...

CASI - Week In Review: Grifols Pays $1.9 Billion For 26% Stake In Shanghai RAAS

Deals and Financings Grifols (MCE: GRF, [[GRFS]]), a Barcelona maker of plasma-based medicines, acquired a 26% stake in Shanghai RAAS (SHZ: 002252), one of China's largest blood plasma companies, for $1.9 billion in a non-cash deal. Grifols will exchange a 45% ownership in its US subsidi...

CASI - CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Registration Trial For MARQIBO®

ROCKVILLE, Md. , March 7, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China , U.S., and throughout the world, a...
Previous 10 Next 10